An insulin pump maker is recalling certain pods that can fail to fully infuse insulin in the body. The recall comes after 18 reports of “serious adverse events." ...

A long-term analysis offers reassurance to users of the topical treatment recently approved for children down to age 2.

Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Interim results from the COMMAND study evaluating the ...

UPPSALA, Sweden, Jan. 9, 2026 /PRNewswire/ -- Synartro is advancing the candidate drug SYN321, a novel intra-articular treatment for knee osteoarthritis, through a phase 1/2a clinical study focused on ...

Demonstrators rally in support of abortion rights at the US Supreme Court in Washington, DC, April 15, 2023. - The Court on April 14 temporarily preserved access to mifepristone, a widely used ...

The FDA has placed a clinical hold on Novavax’s application for its COVID-19-Influenza combination and standalone influenza vaccine candidates following a report of a “serious adverse event.” The ...

Patients given ester-based local anesthetics may be at greater risk of having serious complications when they are administered numbing agents, according to a study published on March 31 in the ...

FDA-approved Andexxa reversed Xarelto and Eliquis bleeding but was linked to higher rates of blood clots and death, raising serious patient safety concerns Andexxa was marketed as the solution to stop ...